(Q26859466)

English

Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease

scientific article

In more languages

Statements

scholarly article

1 reference

Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease (English)

1 reference

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

B. J. Monk

1

1 reference

E. Pujade-Lauraine

2

1 reference

R. A. Burger

3

1 reference

language of work or name

1 reference

publication date

December 2013

1 reference

Annals of Oncology

1 reference

24 Suppl 10

1 reference

x53-x58

1 reference

Identifiers

10.1093/ANNONC/MDT472

0 references

PubMed publication ID

1 reference

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26859466&oldid=1243783384"